Key details
Collaborators
Peking University Cancer Hospital & Institute, Fudan University
Enrollment target
~74 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated February 2025